KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Change in Inventory data on record, last reported at -$1.7 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 75.44% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached $126000.0, up 117.38%, while the annual FY2025 figure was $126000.0, 117.38% up from the prior year.
  • Change in Inventory reached -$1.7 million in Q4 2025 per AQST's latest filing, down from -$241000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.7 million in Q3 2022 and bottomed at -$1.7 million in Q4 2025.
  • Average Change in Inventory over 5 years is $185500.0, with a median of $196500.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: surged 7054.17% in 2022, then plummeted 538.18% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $1.2 million in 2021, then tumbled by 180.34% to -$944000.0 in 2022, then soared by 67.16% to -$310000.0 in 2023, then crashed by 215.16% to -$977000.0 in 2024, then crashed by 75.44% to -$1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$1.7 million in Q4 2025, -$241000.0 in Q3 2025, and $927000.0 in Q2 2025.